Story
AutoZone Shares Jump as Strong Margins Outweigh Revenue Miss

Summary
The auto parts retailer reported fiscal fourth-quarter earnings that surpassed analyst expectations, driven by significant margin expansion, even as revenue fell short of forecasts for the fourth consecutive quarter.
AutoZone (NYSE: AZO) shares surged on Tuesday after the company reported fiscal fourth-quarter results that beat earnings estimates, providing relief to investors after a period of underperformance. The stock's rally was fueled by significant margin expansion and a confident management outlook, which overshadowed a persistent weakness in top-line revenue.
Earnings Beat Masks Sales Concerns
For the full fiscal year 2026, AutoZone posted earnings per share of $152.55, exceeding the Wall Street consensus of $150.63. The result marked the third consecutive quarterly earnings beat for the company. Operating profit for the quarter climbed 10.1% to $1.3 billion.
However, full-year revenue of $20.34 billion, while up 7.4% year-over-year, missed the expected $20.45 billion. This report marks the fourth straight quarter where the company's revenue has fallen short of analyst projections, highlighting an ongoing challenge with sales momentum.
A key driver of the positive earnings surprise was a significant expansion in gross margin, which grew by 182 basis points year-over-year to 53.3%. The company attributed this improvement to a 145 basis point benefit from one-time tariff refunds and a 105 basis point non-cash LIFO accounting gain.
Spotlight on Future Growth
Despite the revenue miss, AutoZone's management expressed confidence in its outlook for fiscal year 2027, anticipating an acceleration in sales across the U.S., Mexico, and Brazil. The company noted particular strength in its domestic commercial, or "do-it-for-me" (DIFM), business segment.
AdFor investors, the report frames a clear debate: AutoZone's proven ability to manage costs and deliver profits versus its struggle to generate consistent top-line growth. While Tuesday's stock gain of over 6% suggests the market was braced for worse news, the shares remain down more than 12% year-to-date.
Catalysts and Metrics to Watch
Analysts and investors will now focus on the company's next earnings report in November for confirmation of the guided sales acceleration. The key metric will be domestic comparable-store sales, which the market wants to see grow organically.
Other critical factors for the company's performance in fiscal 2027 include:
- Margin sustainability: Whether profitability can be maintained without the one-time benefits seen in the fourth quarter.
- Commercial growth: Continued momentum in the higher-frequency commercial segment is seen as crucial for improving revenue quality.
- Store expansion: The company plans to open 90-95 new stores globally per quarter, and its execution will be a signal of long-term confidence.
Following the report, Evercore ISI lowered its price target on AutoZone to $3,500 from $3,700, while Barclays maintained its Buy rating. The consensus price target among analysts implies significant potential upside from current levels.
Read next
More on Stocks
Anthropic Launches Cheaper, Faster Claude 5.5 AI Model Ahead of Potential IPO
Anthropic has released its new flagship AI model, Claude Opus 5.5, which the company says is 40% cheaper and over 30% faster for enterprise use. The launch intensifies competition in the AI sector as the startup reportedly prepares for an initial public offering.

Bank of America Lifts Cybersecurity Price Targets on AI Threat Concerns
Bank of America has raised its price objectives for CrowdStrike, Okta, and SailPoint, citing growing investor recognition that artificial intelligence creates new security risks requiring significant investment. The cybersecurity sector has recently outperformed the broader market as the focus shifts to AI governance and threat mitigation.

AnaptysBio Stock Drops Despite Massive Q2 Earnings Beat as GSK Court Ruling Looms
AnaptysBio reported a significant earnings and revenue surprise for the second quarter, driven by strong Jemperli royalties. However, shares fell as investor attention remains fixed on the pending outcome of a key court case with partner GSK.

Costco, Darden Earnings to Test U.S. Consumer and Business Health This Week
A series of key corporate earnings reports, led by Costco, Darden Restaurants, and Paychex, will provide investors with a critical, real-time look at the health of U.S. consumer spending and small business hiring.